Insulin Pricing Debate

Scott and Rod discuss the disparity between insulin manufacturing costs and retail prices, highlighting the impact on individuals without insurance. They delve into the ethical implications of profit margins in the healthcare industry and the challenges faced by disadvantaged families in accessing essential medication.